Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV+ status in head and neck cancer.

Lu S, Concha-Benavente F, Shayan G, Srivastava RM, Gibson SP, Wang L, Gooding WE, Ferris RL.

Oral Oncol. 2018 Mar;78:186-193. doi: 10.1016/j.oraloncology.2018.01.019. Epub 2018 Feb 20.

2.

Time for introspection.

Agrawal S, Srivastava RM, Singh V.

Indian J Ophthalmol. 2018 Feb;66(2):339. doi: 10.4103/ijo.IJO_779_17. No abstract available.

3.

Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals.

Shayan G, Kansy BA, Gibson SP, Srivastava RM, Bryan JK, Bauman JE, Ohr J, Kim S, Duvvuri U, Clump DA, Heron DE, Johnson JT, Hershberg RM, Ferris RL.

Clin Cancer Res. 2018 Jan 1;24(1):62-72. doi: 10.1158/1078-0432.CCR-17-0357. Epub 2017 Oct 23.

4.

PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.

Kansy BA, Concha-Benavente F, Srivastava RM, Jie HB, Shayan G, Lei Y, Moskovitz J, Moy J, Li J, Brandau S, Lang S, Schmitt NC, Freeman GJ, Gooding WE, Clump DA, Ferris RL.

Cancer Res. 2017 Nov 15;77(22):6353-6364. doi: 10.1158/0008-5472.CAN-16-3167. Epub 2017 Sep 13.

5.

Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma.

Kikuchi M, Clump DA, Srivastava RM, Sun L, Zeng D, Diaz-Perez JA, Anderson CJ, Edwards WB, Ferris RL.

Oncoimmunology. 2017 May 19;6(7):e1329071. doi: 10.1080/2162402X.2017.1329071. eCollection 2017.

6.

Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients.

Mazorra Z, Lavastida A, Concha-Benavente F, Valdés A, Srivastava RM, García-Bates TM, Hechavarría E, González Z, González A, Lugiollo M, Cuevas I, Frómeta C, Mestre BF, Barroso MC, Crombet T, Ferris RL.

Front Pharmacol. 2017 Jun 19;8:382. doi: 10.3389/fphar.2017.00382. eCollection 2017.

7.

Increased PD-1+ and TIM-3+ TILs during Cetuximab Therapy Inversely Correlate with Response in Head and Neck Cancer Patients.

Jie HB, Srivastava RM, Argiris A, Bauman JE, Kane LP, Ferris RL.

Cancer Immunol Res. 2017 May;5(5):408-416. doi: 10.1158/2326-6066.CIR-16-0333. Epub 2017 Apr 13.

8.

Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients.

Trivedi S, Srivastava RM, Concha-Benavente F, Ferrone S, Garcia-Bates TM, Li J, Ferris RL.

Clin Cancer Res. 2016 Nov 1;22(21):5229-5237. Epub 2016 May 23.

9.

CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer.

Srivastava RM, Trivedi S, Concha-Benavente F, Gibson SP, Reeder C, Ferrone S, Ferris RL.

Clin Cancer Res. 2017 Feb 1;23(3):707-716. doi: 10.1158/1078-0432.CCR-16-0879. Epub 2016 Aug 5.

10.

The development of a low-cost three-dimensional printed shoulder, arm, and hand prostheses for children.

Zuniga JM, Carson AM, Peck JM, Kalina T, Srivastava RM, Peck K.

Prosthet Orthot Int. 2017 Apr;41(2):205-209. doi: 10.1177/0309364616640947. Epub 2016 Jul 10.

PMID:
27117013
11.

Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer.

Concha-Benavente F, Srivastava RM, Trivedi S, Lei Y, Chandran U, Seethala RR, Freeman GJ, Ferris RL.

Cancer Res. 2016 Mar 1;76(5):1031-43. doi: 10.1158/0008-5472.CAN-15-2001. Epub 2015 Dec 16.

12.

Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients.

Li J, Srivastava RM, Ettyreddy A, Ferris RL.

J Immunother Cancer. 2015 Nov 17;3:54. doi: 10.1186/s40425-015-0097-6. eCollection 2015.

13.

Transscleral fixation of closed loop haptic acrylic posterior chamber intraocular lens in aphakic nonvitrectomized eyes.

Agrawal S, Singh V, Gupta SK, Misra N, Srivastava RM.

Indian J Ophthalmol. 2015 Aug;63(8):649-53. doi: 10.4103/0301-4738.169797.

14.

STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.

Srivastava RM, Trivedi S, Concha-Benavente F, Hyun-Bae J, Wang L, Seethala RR, Branstetter BF 4th, Ferrone S, Ferris RL.

Cancer Immunol Res. 2015 Aug;3(8):936-45. doi: 10.1158/2326-6066.CIR-15-0053. Epub 2015 May 13.

15.

CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.

Jie HB, Schuler PJ, Lee SC, Srivastava RM, Argiris A, Ferrone S, Whiteside TL, Ferris RL.

Cancer Res. 2015 Jun 1;75(11):2200-10. doi: 10.1158/0008-5472.CAN-14-2788. Epub 2015 Apr 1.

16.

Quality of life, disability scores, and distress index in fungal rhinosinusitis.

Srivastava RM, Rijuneeta, Gupta AK, Patro SK, Avasthi A.

Med Mycol. 2014 Oct;52(7):706-14. doi: 10.1093/mmy/myu037. Epub 2014 Jul 16.

PMID:
25031427
17.

Immune biomarkers of anti-EGFR monoclonal antibody therapy.

Trivedi S, Concha-Benavente F, Srivastava RM, Jie HB, Gibson SP, Schmitt NC, Ferris RL.

Ann Oncol. 2015 Jan;26(1):40-7. doi: 10.1093/annonc/mdu156. Epub 2014 Jul 4. Review.

18.

EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3.

Concha-Benavente F, Srivastava RM, Ferrone S, Ferris RL.

Oncoimmunology. 2013 Dec 1;2(12):e27215. Epub 2013 Dec 5.

19.

Determinants of severity at presentation among young patients with early onset glaucoma.

Gupta V, Srivastava RM, Sihota R, Kaur J, Kumar S, Singh D.

Indian J Ophthalmol. 2013 Oct;61(10):546-51. doi: 10.4103/0301-4738.121064.

20.

Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity.

Moreira DR, Leite AC, Cardoso MV, Srivastava RM, Hernandes MZ, Rabello MM, da Cruz LF, Ferreira RS, de Simone CA, Meira CS, Guimaraes ET, da Silva AC, dos Santos TA, Pereira VR, Soares MB.

ChemMedChem. 2014 Jan;9(1):177-88. doi: 10.1002/cmdc.201300354. Epub 2013 Nov 7.

PMID:
24203393
21.

Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.

Jie HB, Gildener-Leapman N, Li J, Srivastava RM, Gibson SP, Whiteside TL, Ferris RL.

Br J Cancer. 2013 Nov 12;109(10):2629-35. doi: 10.1038/bjc.2013.645. Epub 2013 Oct 29.

22.

Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.

Srivastava RM, Lee SC, Andrade Filho PA, Lord CA, Jie HB, Davidson HC, López-Albaitero A, Gibson SP, Gooding WE, Ferrone S, Ferris RL.

Clin Cancer Res. 2013 Apr 1;19(7):1858-72. doi: 10.1158/1078-0432.CCR-12-2426. Epub 2013 Feb 26.

23.

SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.

Leibowitz MS, Srivastava RM, Andrade Filho PA, Egloff AM, Wang L, Seethala RR, Ferrone S, Ferris RL.

Clin Cancer Res. 2013 Feb 15;19(4):798-808. doi: 10.1158/1078-0432.CCR-12-1517. Epub 2013 Jan 30.

24.

Clinical correlates to the goniodysgensis among juvenile-onset primary open-angle glaucoma patients.

Gupta V, Srivastava RM, Rao A, Mittal M, Fingert J.

Graefes Arch Clin Exp Ophthalmol. 2013 Jun;251(6):1571-6. doi: 10.1007/s00417-013-2262-2. Epub 2013 Jan 29.

PMID:
23358655
25.

Larvicidal isoxazoles: Synthesis and their effective susceptibility towards Aedes aegypti larvae.

da Silva-Alves DC, dos Anjos JV, Cavalcante NN, Santos GK, Navarro DM, Srivastava RM.

Bioorg Med Chem. 2013 Feb 15;21(4):940-7. doi: 10.1016/j.bmc.2012.12.006. Epub 2012 Dec 13.

PMID:
23321014
26.

Structural investigation of anti-Trypanosoma cruzi 2-iminothiazolidin-4-ones allows the identification of agents with efficacy in infected mice.

Moreira DR, Costa SP, Hernandes MZ, Rabello MM, de Oliveira Filho GB, de Melo CM, da Rocha LF, de Simone CA, Ferreira RS, Fradico JR, Meira CS, Guimarães ET, Srivastava RM, Pereira VR, Soares MB, Leite AC.

J Med Chem. 2012 Dec 27;55(24):10918-36. doi: 10.1021/jm301518v. Epub 2012 Dec 7.

PMID:
23167554
27.

Synthesis of 1,2,3-triazole derivatives and in vitro antifungal evaluation on Candida strains.

Lima-Neto RG, Cavalcante NN, Srivastava RM, Mendonça Junior FJ, Wanderley AG, Neves RP, dos Anjos JV.

Molecules. 2012 May 16;17(5):5882-92. doi: 10.3390/molecules17055882.

28.

Comparative computational studies of 3,4-dihydro-2,6-diaryl-4-oxo-pyrimidine-5-carbonitrile derivatives as potential antinociceptive agents.

dos Anjos JV, Srivastava RM, Costa-Silva JH, Scotti L, Scotti MT, Wanderley AG, Leite ES, de Melo SJ, Mendonça Junior FJ.

Molecules. 2012 Jan 16;17(1):809-19. doi: 10.3390/molecules17010809.

29.

Consequences of alteration in leucine zipper sequence of melittin in its neutralization of lipopolysaccharide-induced proinflammatory response in macrophage cells and interaction with lipopolysaccharide.

Srivastava RM, Srivastava S, Singh M, Bajpai VK, Ghosh JK.

J Biol Chem. 2012 Jan 13;287(3):1980-95. doi: 10.1074/jbc.M111.302893. Epub 2011 Nov 29.

30.

Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity.

Lee SC, Srivastava RM, López-Albaitero A, Ferrone S, Ferris RL.

Immunol Res. 2011 Aug;50(2-3):248-54. doi: 10.1007/s12026-011-8231-0. Review.

31.

Immunomodulatory and therapeutic activity of curcumin.

Srivastava RM, Singh S, Dubey SK, Misra K, Khar A.

Int Immunopharmacol. 2011 Mar;11(3):331-41. doi: 10.1016/j.intimp.2010.08.014. Epub 2010 Sep 8. Review.

PMID:
20828642
32.

Structure-activity relationships of mononuclear metal-thiosemicarbazone complexes endowed with potent antiplasmodial and antiamoebic activities.

Bahl D, Athar F, Soares MB, de Sá MS, Moreira DR, Srivastava RM, Leite AC, Azam A.

Bioorg Med Chem. 2010 Sep 15;18(18):6857-64. doi: 10.1016/j.bmc.2010.07.039. Epub 2010 Jul 21.

PMID:
20719524
33.

Cell-selective lysis by novel analogues of melittin against human red blood cells and Escherichia coli.

Pandey BK, Ahmad A, Asthana N, Azmi S, Srivastava RM, Srivastava S, Verma R, Vishwakarma AL, Ghosh JK.

Biochemistry. 2010 Sep 14;49(36):7920-9. doi: 10.1021/bi100729m.

PMID:
20695504
34.

Design of nontoxic analogues of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine zipper sequences in determining its toxicity.

Ahmad A, Azmi S, Srivastava RM, Srivastava S, Pandey BK, Saxena R, Bajpai VK, Ghosh JK.

Biochemistry. 2009 Nov 24;48(46):10905-17. doi: 10.1021/bi9009874.

PMID:
19845398
35.

Structure-function study of cathelicidin-derived bovine antimicrobial peptide BMAP-28: design of its cell-selective analogs by amino acid substitutions in the heptad repeat sequences.

Ahmad A, Asthana N, Azmi S, Srivastava RM, Pandey BK, Yadav V, Ghosh JK.

Biochim Biophys Acta. 2009 Nov;1788(11):2411-20. doi: 10.1016/j.bbamem.2009.08.021. Epub 2009 Sep 6.

36.

Dendritic cells and their receptors in antitumor immune response.

Srivastava RM, Khar A.

Curr Mol Med. 2009 Aug;9(6):708-24. Review.

PMID:
19689298
37.

Improved microwave-mediated synthesis of 3-(3-aryl-1,2,4-oxadiazol-5-yl)propionic acids and their larvicidal and fungal growth inhibitory properties.

Neves Filho RA, da Silva CA, da Silva CS, Brustein VP, do Amaral Ferraz Navarro DM, dos Santos FA, Alves LC, dos Santos Cavalcanti MG, Srivastava RM, das Graças Carneiro-Da-Cunha M.

Chem Pharm Bull (Tokyo). 2009 Aug;57(8):819-25.

38.

First ultrasound-mediated one-pot synthesis of N-substituted amides.

Srivastava RM, Neves Filho RA, da Silva CA, Bortoluzzi AJ.

Ultrason Sonochem. 2009 Aug;16(6):737-42. doi: 10.1016/j.ultsonch.2009.04.006. Epub 2009 Apr 23.

PMID:
19435673
39.

Synthesis and cytotoxic profile of glycosyl-triazole linked to 1,2,4-oxadiazole moiety at C-5 through a straight-chain carbon and oxygen atoms.

dos Anjos JV, Neves Filho RA, do Nascimento SC, Srivastava RM, de Melo SJ, Sinou D.

Eur J Med Chem. 2009 Sep;44(9):3571-6. doi: 10.1016/j.ejmech.2009.03.002. Epub 2009 Mar 19.

PMID:
19345445
40.

Immunomodulatory effects of curcumin: in-vivo.

Varalakshmi Ch, Ali AM, Pardhasaradhi BV, Srivastava RM, Singh S, Khar A.

Int Immunopharmacol. 2008 May;8(5):688-700. doi: 10.1016/j.intimp.2008.01.008. Epub 2008 Feb 13.

PMID:
18387511
42.

3-[3-(3-Fluoro-phen-yl)-1,2,4-oxadiazol-5-yl]propionic acid.

Santos SK, Neves Filho RA, Bortoluzzi AJ, Srivastava RM.

Acta Crystallogr Sect E Struct Rep Online. 2008 Dec 17;65(Pt 1):o146. doi: 10.1107/S1600536808042001.

43.
44.

Synthesis of glycosyl-triazole linked 1,2,4-oxadiazoles.

dos Anjos JV, Sinou D, de Melo SJ, Srivastava RM.

Carbohydr Res. 2007 Nov 26;342(16):2440-9. Epub 2007 Jul 21.

PMID:
17689508
45.

Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response.

Srivastava RM, Varalakshmi Ch, Khar A.

Int Immunol. 2007 May;19(5):591-607. Epub 2007 Mar 15.

PMID:
17369187
46.

Synthesis and antiinflammatory activity of 4-amino-2-aryl-5-cyano-6-{3- and 4-(N-phthalimidophenyl)} pyrimidines.

Falcão EP, de Melo SJ, Srivastava RM, Catanho MT, Do Nascimento SC.

Eur J Med Chem. 2006 Feb;41(2):276-82. Epub 2006 Jan 18.

PMID:
16414151
47.

Genotoxic activity of 3-[3-phenyl-1,2,4-oxadiazol-5-yl] propionic acid and its peptidyl derivatives determined by Ames and SOS response tests.

Leite AC, Vieira RF, de M Moreira DR, Brondani DJ, Srivastava RM, da Silva VF, de Morais Júnior MA.

Mutat Res. 2005 Dec 30;588(2):166-71. Epub 2005 Dec 1.

PMID:
16325458
48.

Synthesis of 3-aryl-5-decapentyl-1,2,4-oxadiazoles possessing antiinflammatory and antitumor properties.

Bezerra NM, De Oliveira SP, Srivastava RM, Da Silva JR.

Farmaco. 2005 Nov-Dec;60(11-12):955-60. Epub 2005 Oct 20.

PMID:
16242685
49.

Total synthesis and identification of two diastereoisomers of 1-methyl-2-[N-(p-tolylsulfonyl)-2-pyrrolidinyl]ethyl beta-L-fucopyranoside.

E Silva MJ, Cottier L, Srivastava RM, Sinou D, Thozet A.

Carbohydr Res. 2005 Feb 7;340(2):309-14.

PMID:
15639251
50.

Mass spectrometric analysis of 1,2,4-oxadiazoles and 4,5-dihydro-1,2,4-oxadiazoles.

Srivastava RM.

Mass Spectrom Rev. 2005 May-Jun;24(3):328-46. Review.

PMID:
15389853

Supplemental Content

Loading ...
Support Center